Please note: Work is currently underway to update content available on this site.
Director Letters (formerly MELs/CELs/HDLs etc) are currently being reviewed to ensure it is clear which publications are current, superseded or obsolete.
Director Letters (formerly MELs/CELs/HDLs etc) are currently being reviewed to ensure it is clear which publications are current, superseded or obsolete.
Publication #7549
Reference
Drug alert 09/2022
Name
Drug alert class 4 – 09 2022 – Caution in use - class 4 medicines defect information: Atnahs Pharma UK Limited, Naprosyn tablets (all strengths), Naprosyn EC 500mg gastro-resistant tablets
Categories
Scottish Government
Drug Alerts
Organization
Scottish Government Health and Social Care Directorates
Keywords
NHS
SCOTLAND
DRUGS
SAFETY
RISKS
PHARMACEUTICAL INDUSTRY
DEFECT INFORMATION
Description
Additional to the batches included in the previous Class 4 Medicines Notification (reference EL(22)A/05), Atnahs Pharma UK Limited have informed us that the Patient Information Leaflets (PILs) in the above batches are missing the following information (in bold): Section 2: Other medicines and Naprosyn Tablets Talk to your doctor or pharmacist if you are taking, have recently taken or might take any other medicines. This includes medicines that you buy without a prescription and herbal medicines. In particular tell you doctor or pharmacist if you are taking: Medicine to stop your blood clotting, like aspirin/acetylsalicylic acid, warfarin, heparin or clopidogrel.
Contact Name
Grace Jamieson
Contact Email
Contact Address
Contact Phone
Created
2022-02-23 00:00:00
Click to go back to homepage